Literature DB >> 2562244

Evidence for differential expression of CD45 isoforms by precursors for memory-dependent and independent cytotoxic responses: human CD8 memory CTLp selectively express CD45RO (UCHL1).

M Merkenschlager1, P C Beverley.   

Abstract

On the basis of differential CD45 expression, human T cells can be separated into approximately reciprocal populations. The mAb UCHL1 detects a 180 kd molecular mass isoform, CD45R0. The CD45RA cluster of mAbs reacts with CD45 isoforms of 205 and 220 kd molecular mass. These reagents subdivide both CD4 and CD8 T cell populations. CD4 T cells that proliferate in response to memory-dependent (recall) antigens have been shown to selectively express CD45R0. We extend these observations to a model for cytotoxic responses that allows the functional analysis of CD8 T cells with differential CD45 expression. Precursors for allo-specific CTL responses are readily detectable in CD45R0 as well as CD45RA populations. In contrast, we find memory CTLp greatly enriched among CD45R0 cells. In combination with earlier work, these results suggest that differential expression of CD45 isoforms is associated with memory formation for different classes of immune responses in both major T cell lineages.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562244     DOI: 10.1093/intimm/1.4.450

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  40 in total

Review 1.  Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis.

Authors:  L R Wedderburn; P Woo
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Ex vivo analysis of phenotype and TCR usage in relation to CD45 isoform expression on cytomegalovirus-specific CD8+ T lymphocytes.

Authors:  A L Vargas; F Lechner; M Kantzanou; R E Phillips; P Klenerman
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

Review 3.  Qualitative differences between naïve and memory T cells.

Authors:  Marion Berard; David F Tough
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

4.  Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

Authors:  G M Gillespie; M R Wills; V Appay; C O'Callaghan; M Murphy; N Smith; P Sissons; S Rowland-Jones; J I Bell; P A Moss
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Travels in time: assessing the functional complexity of T cells.

Authors:  W Nicholas Haining
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-20       Impact factor: 11.205

Review 6.  Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs.

Authors:  Alberto Sánchez-Fueyo; Terry B Strom
Journal:  Gastroenterology       Date:  2010-11-09       Impact factor: 22.682

Review 7.  CD45 isoform expression: implications for recirculation of naive and memory cells.

Authors:  P C Beverley
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 8.  Viewing transplantation immunology through today's lens: new models, new imaging, and new insights.

Authors:  Alex Y Huang; W Nicholas Haining; Deborah S Barkauskas; Jay T Myers; Agne Petrosiute; Aneesah P Garrett; Karnail Singh; Kenneth R Cooke; Leslie S Kean
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-22       Impact factor: 5.742

9.  Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection.

Authors:  Matthew R Pipeling; Erin E West; Christine M Osborne; Amanda B Whitlock; Lesia K Dropulic; Matthew H Willett; Michael Forman; Alexandra Valsamakis; Jonathan B Orens; David R Moller; Noah Lechtzin; Stephen A Migueles; Mark Connors; John F McDyer
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Phenotypic characterization of CD8+ T cell populations in HIV disease and in anti-HIV immunity.

Authors:  K C Watret; J A Whitelaw; K S Froebel; A G Bird
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.